Abdominal pain is a common complaint in clinical practice, often presenting as a diagnostic enigma due to its broad range of potential etiologies. A systematic approach to evaluating abdominal pain is essential to narrow down the diagnosis and guide appropriate management.
A comprehensive history is the cornerstone of evaluating abdominal pain. The clinician should focus on the onset, location, character, radiation, associated symptoms, and aggravating or relieving factors. Understanding the patient's past medical history, surgical history, and family history can also provide valuable clues.
An extensive physical examination can help localize the pain and identify potential signs of serious conditions. Inspection, auscultation, palpation, and percussion are key components of the examination. Special attention should be paid to signs of peritonitis, which may indicate a surgical emergency.
Investigations should be tailored to the suspected diagnosis based on the history and physical examination. Basic investigations include complete blood count, renal function tests, liver function tests, and urinalysis. Imaging studies, such as ultrasound or CT scan, may be necessary in certain cases.
Management depends on the underlying cause of the abdominal pain. Analgesics should be used judiciously, as they may mask the symptoms and complicate the diagnosis. Empirical treatment should be avoided unless there is a strong suspicion of a specific diagnosis.
Evaluating abdominal pain in clinical practice requires a systematic approach, starting from a comprehensive history and physical examination, followed by appropriate investigations. Clinicians should always be aware of the potential for serious conditions and manage the patient accordingly. This comprehensive guide aims to aid clinicians in their quest to unravel the complexities of abdominal pain and deliver the best care to their patients.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation